Skip to main content
Premium Trial:

Request an Annual Quote

Back to the Bench

Harvard University's provost, Steven Hyman, is stepping down at the end of the academic year to return to research, reports The Boston Globe. Hyman is a trained neuroscientist and he plans to take a sabbatical year at the Broad Institute, which the Globe notes, was one of Hyman's efforts to spur interdisciplinary research. "I had intended to do this [job] for five years ... but things at Harvard were turbulent and complicated, and it seemed wrong to step away from this at times of difficulty," Hyman tells the Globe, which adds that Harvard has gotten through the resignation of Larry Summers and the financial crisis. "Part of the timing now, besides the fact that 10 years is a good run, is that Harvard has weathered a lot of storms and has a very strong leadership team and strong president and is doing fine."

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.